{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.1010","meta":{"versionId":"5","lastUpdated":"2020-09-12T01:00:28.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Clinical Architecture"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-06-21"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2020-09-12"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1010","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.3616.200.110.102.1010"}],"version":"20200912","name":"IntravesicalAdministrationOfBacilleCalmetteGuérinBCG","title":"Intravesical Administration of Bacille Calmette Guérin (BCG)","status":"retired","experimental":false,"date":"2023-06-21T18:16:37-04:00","publisher":"Clinical Architecture","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values contains terms related to intravesical administration of Bacille Calmette-Guérin (BCG).),(Data Element Scope: ),(Inclusion Criteria: Includes intravesical administration of BCG.),(Exclusion Criteria: Excludes other routes of administration.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","concept":[{"code":"J9030","display":"Bcg live intravesical instillation, 1 mg"},{"code":"J9031","display":"Bcg (intravesical) per instillation"}]}]},"expansion":{"identifier":"urn:uuid:5b0c75ca-8117-4785-a9ab-4efc1ff975d1","timestamp":"2023-12-11T01:34:03-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J9030","display":"Bcg live intravesical instillation, 1 mg"}]}}